We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
26
S&P Global
SPGI
$126B
$59.9M 1.03%
473,109
-13,940
-3% -$1.67M
BAH icon
27
Booz Allen Hamilton
BAH
$8.7B
$57.2M 0.99%
1,810,263
-55,326
-3% -$1.69M
DOX icon
28
Amdocs
DOX
$5.53B
$55.8M 0.96%
963,893
-86,610
-8% -$5.1M
CNQ icon
29
Canadian Natural Resources
CNQ
$96.9B
$52.7M 0.91%
+2,876,960
New +$43.8M
UNP icon
30
Union Pacific
UNP
$183B
$52.2M 0.9%
535,623
-26,212
-5% -$2.45M
TWTR
31
CALL
DELISTED
Twitter, Inc.
TWTR
$49.6M 0.86%
+2,150,000
New +$40.5M
MRSH
32
Marsh
MRSH
$86.3B
$48.1M 0.83%
715,000
+20,000
+3% +$1.34M
ICLR icon
33
Icon
ICLR
$12.8B
$48M 0.83%
619,893
-18,273
-3% -$1.37M
SPLK
34
DELISTED
Splunk Inc
SPLK
$46M 0.79%
783,658
+92,541
+13% +$5.54M
ABT icon
35
Abbott
ABT
$180B
$43.1M 0.74%
1,020,000
+870,000
+580% +$37.3M
ACN icon
36
Accenture
ACN
$89.9B
$41.3M 0.71%
337,795
-51,815
-13% -$5.9M
AMGN icon
37
Amgen
AMGN
$203B
$39M 0.67%
234,013
+207,139
+771% +$35M
CELG
38
DELISTED
Celgene Corp
CELG
$36.1M 0.62%
345,500
+258,129
+295% +$27.9M
EA icon
39
Electronic Arts
EA
$52.4B
$35.8M 0.62%
419,935
+91,497
+28% +$7.32M
EGHT icon
40
8x8 Inc
EGHT
$247M
$35M 0.6%
2,269,541
+470,463
+26% +$6.69M
ADBE icon
41
Adobe
ADBE
$89.5B
$34.9M 0.6%
321,895
+74,669
+30% +$7.49M
AON icon
42
Aon
AON
$77.3B
$34.9M 0.6%
309,898
-24,925
-7% -$2.75M
TMO icon
43
Thermo Fisher Scientific
TMO
$211B
$34.6M 0.6%
217,406
-139,615
-39% -$21.5M
ACM icon
44
Aecom
ACM
$9.07B
$34.6M 0.6%
1,162,872
-359,386
-24% -$11.6M
CYBR
45
DELISTED
CyberArk
CYBR
$33.2M 0.57%
669,006
+15,085
+2% +$803K
MU icon
46
Micron Technology
MU
$1.04T
$33M 0.57%
1,854,734
-61,423
-3% -$937K
MDSO
47
DELISTED
Medidata Solutions, Inc.
MDSO
$32.6M 0.56%
585,460
-123,926
-17% -$6.57M
MEOH icon
48
Methanex
MEOH
$4.32B
$32.6M 0.56%
912,866
-68,737
-7% -$2.03M
UNH icon
49
UnitedHealth
UNH
$382B
$32.5M 0.56%
232,000
-86,000
-27% -$12M
PFPT
50
DELISTED
Proofpoint, Inc.
PFPT
$31.2M 0.54%
416,375
-80,200
-16% -$5.92M
1
2
3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.